searay2701
13 minutes ago
This is the year, 2025, IVDN, after expenses, must see a steady net profit from this business. This stock hinges on this company staying up to date on it’s OTC reporting and being, after so long in business, a profitable operation. Lately, we seem to be heading in the right direction, only more time